Procaterol: Difference between revisions
m Protected "Procaterol": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
Rabin Bista (talk | contribs) No edit summary |
||
| Line 23: | Line 23: | ||
| routes_of_administration = Oral, inhalation | | routes_of_administration = Oral, inhalation | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
== Overview == | |||
==Overview== | |||
'''Procaterol''', also known as procaterol hydrochloride ([[United States Adopted Name|USAN]]), is a short-acting [[beta2-adrenergic receptor agonist|β<sub>2</sub>-adrenergic receptor agonist]] used for the treatment of asthma. It has never been filed for [[Food and Drug Administration|FDA]] evaluation in the [[United States]], where it is not marketed. | '''Procaterol''', also known as procaterol hydrochloride ([[United States Adopted Name|USAN]]), is a short-acting [[beta2-adrenergic receptor agonist|β<sub>2</sub>-adrenergic receptor agonist]] used for the treatment of asthma. It has never been filed for [[Food and Drug Administration|FDA]] evaluation in the [[United States]], where it is not marketed. | ||
| Line 34: | Line 33: | ||
{{Asthma and copd rx}} | {{Asthma and copd rx}} | ||
[[Category:drug]] | |||
[[Category:Beta-adrenergic agonists]] | [[Category:Beta-adrenergic agonists]] | ||
Latest revision as of 16:11, 13 April 2015
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral, inhalation |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C16H22N2O3 |
| Molar mass | 290.357 g/mol |
|
WikiDoc Resources for Procaterol |
|
Articles |
|---|
|
Most recent articles on Procaterol |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Procaterol at Clinical Trials.gov Clinical Trials on Procaterol at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Procaterol
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Procaterol Discussion groups on Procaterol Patient Handouts on Procaterol Directions to Hospitals Treating Procaterol Risk calculators and risk factors for Procaterol
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Procaterol |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Procaterol, also known as procaterol hydrochloride (USAN), is a short-acting β2-adrenergic receptor agonist used for the treatment of asthma. It has never been filed for FDA evaluation in the United States, where it is not marketed.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Beta-adrenergic agonists